1
|
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.
|
Osteoarthritis Cartilage
|
2008
|
10.99
|
2
|
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.
|
Osteoarthritis Cartilage
|
2010
|
7.52
|
3
|
Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology.
|
Arthritis Rheum
|
1995
|
5.32
|
4
|
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.
|
Osteoarthritis Cartilage
|
2007
|
4.34
|
5
|
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.
|
Osteoarthritis Cartilage
|
2004
|
4.01
|
6
|
Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology.
|
Arthritis Rheum
|
1995
|
3.05
|
7
|
Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging.
|
Ann Rheum Dis
|
2004
|
2.89
|
8
|
Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative.
|
Osteoarthritis Cartilage
|
2000
|
2.42
|
9
|
Angioid streaks.
|
Surv Ophthalmol
|
1982
|
2.02
|
10
|
Drug interactions between oral contraceptives and antibiotics.
|
Obstet Gynecol
|
2001
|
1.72
|
11
|
Should subchondral bone turnover be targeted when treating osteoarthritis?
|
Osteoarthritis Cartilage
|
2008
|
1.50
|
12
|
Development of clinical criteria for osteoarthritis.
|
J Rheumatol
|
1987
|
1.46
|
13
|
Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
|
N Engl J Med
|
1973
|
1.41
|
14
|
Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees.
|
Osteoarthritis Cartilage
|
2003
|
1.41
|
15
|
Musculoskeletal manifestations of Paget's disease of bone.
|
Arthritis Rheum
|
1980
|
1.29
|
16
|
Articular chondrocalcinosis. Microanalysis of pyrophosphate (PPi) in synovial fluid and plasma.
|
Arthritis Rheum
|
1973
|
1.22
|
17
|
Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).
|
J Clin Invest
|
1992
|
1.21
|
18
|
Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International.
|
Osteoarthritis Cartilage
|
2006
|
1.19
|
19
|
Collagenolytic activity and collagen matrix breakdown of the articular cartilage in the Pond-Nuki dog model of osteoarthritis.
|
Arthritis Rheum
|
1983
|
1.16
|
20
|
Digital clubbing and lung cancer.
|
Chest
|
1998
|
1.15
|
21
|
The action of cathepsin D in human articular cartilage on proteoglycans.
|
J Clin Invest
|
1973
|
1.12
|
22
|
Gouty arthritis masquerading as rheumatoid arthritis or vice versa.
|
Semin Arthritis Rheum
|
1978
|
1.11
|
23
|
Inflammation in osteoarthritis.
|
Clin Rheum Dis
|
1985
|
1.10
|
24
|
Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
|
Ann Intern Med
|
1977
|
1.04
|
25
|
Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13).
|
J Biol Chem
|
2000
|
1.02
|
26
|
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study.
|
J Bone Miner Res
|
1998
|
1.00
|
27
|
Low back pain in Paget's disease of bone.
|
Clin Orthop Relat Res
|
1987
|
1.00
|
28
|
Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
|
Clin Orthop Relat Res
|
1983
|
0.98
|
29
|
Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions.
|
Arthritis Rheum
|
1999
|
0.98
|
30
|
Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials.
|
Osteoarthritis Cartilage
|
2009
|
0.97
|
31
|
Degradation of proteoglycans in human osteoarthritic cartilage.
|
Arthritis Rheum
|
1973
|
0.96
|
32
|
Design and conduct of clinical trials in osteoarthritis: preliminary recommendations from a task force of the Osteoarthritis Research Society.
|
J Rheumatol
|
1997
|
0.95
|
33
|
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry.
|
Semin Arthritis Rheum
|
1996
|
0.95
|
34
|
Preferences in the management of osteoarthritis of the hip and knee: results of a survey of community-based rheumatologists in the United States.
|
Arthritis Care Res
|
1996
|
0.94
|
35
|
Hip osteoarthritis prevalence estimates by three radiographic scoring systems.
|
Arthritis Rheum
|
1998
|
0.92
|
36
|
Cathepsin D activity in normal and osteoarthritic human cartilage.
|
Fed Proc
|
1973
|
0.92
|
37
|
Report of the Council on Scientific Affairs. Use of restraints for patients in nursing homes. Council on Scientific Affairs, American Medical Association.
|
Arch Fam Med
|
1999
|
0.90
|
38
|
A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure modifying therapy in osteoarthritis of the hip and knee.
|
Osteoarthritis Cartilage
|
2000
|
0.90
|
39
|
Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients?--a meta-analysis of randomized controlled trials.
|
Osteoarthritis Cartilage
|
2008
|
0.90
|
40
|
Fracture healing and mast cells.
|
J Orthop Trauma
|
1995
|
0.89
|
41
|
Takayasu's arteritis syndrome associated with systemic lupus erythematosus.
|
Semin Arthritis Rheum
|
1992
|
0.89
|
42
|
Biomechanical and biochemical properties of dog cartilage in experimentally induced osteoarthritis.
|
Ann Rheum Dis
|
1984
|
0.89
|
43
|
Alzheimer disease. Report of the Council on Scientific Affairs.
|
Arch Fam Med
|
1999
|
0.87
|
44
|
Updated osteoarthritis reference standard.
|
J Rheumatol Suppl
|
1995
|
0.86
|
45
|
Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA?
|
Osteoarthritis Cartilage
|
2006
|
0.86
|
46
|
Progressive systemic sclerosis in a family: case report of a mother and son and review of the literature.
|
Arthritis Rheum
|
1977
|
0.86
|
47
|
The effects of methotrexate on normal and osteoarthritic lapine articular cartilage.
|
J Rheumatol
|
1993
|
0.85
|
48
|
Rheumatic manifestations in HIV-1 infected in-patients and literature review.
|
Clin Exp Rheumatol
|
2008
|
0.85
|
49
|
Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone.
|
Am J Med
|
1985
|
0.85
|
50
|
Screening nonimmigrant visitors to the United States for tuberculosis: report of the Council on Scientific Affairs.
|
Arch Intern Med
|
2001
|
0.84
|
51
|
Radiographic progression of knee osteoarthritis in a Czech cohort.
|
Clin Exp Rheumatol
|
2000
|
0.84
|
52
|
Treatment of canine osteoarthritis with insulin-like growth factor-1 (IGF-1) and sodium pentosan polysulfate.
|
Osteoarthritis Cartilage
|
1993
|
0.84
|
53
|
Safety of over-the-counter inhalers for asthma: report of the council on scientific affairs.
|
Chest
|
2000
|
0.84
|
54
|
Classical rheumatoid arthritis in a patient with Reiter's syndrome.
|
J Rheumatol
|
1976
|
0.83
|
55
|
Commentary: osteoarthritis of the knee and glucosamine.
|
Osteoarthritis Cartilage
|
2006
|
0.83
|
56
|
Simultaneous multifocal sarcomatous degeneration in Paget's disease of bone. A hypothesis.
|
Clin Orthop Relat Res
|
1983
|
0.82
|
57
|
Degenerative joint disease.
|
Clin Rheum Dis
|
1983
|
0.82
|
58
|
Treatment of osteoarthritis with tiaprofenic acid: biochemical and histological protection against cartilage breakdown in the Pond-Nuki canine model.
|
J Rheumatol Suppl
|
1991
|
0.81
|
59
|
Diagnostic and therapeutic uses of the arthroscope in rheumatoid arthritis and osteoarthritis.
|
Am J Med
|
1983
|
0.81
|
60
|
Aberrant serum enzyme patterns in dermatomyositis associated with hepatoma.
|
J Rheumatol
|
1976
|
0.81
|
61
|
Treatment of Paget disease of bone (osteitis deformans). Results of a one-year study with sodium etidronate.
|
JAMA
|
1974
|
0.80
|
62
|
A 4-week randomized study of acetaminophen extended-release vs rofecoxib in knee osteoarthritis.
|
Osteoarthritis Cartilage
|
2008
|
0.80
|
63
|
Cartilage metalloproteases in disuse atrophy.
|
J Rheumatol Suppl
|
1995
|
0.80
|
64
|
Review of ibuprofen for osteoarthritis.
|
Am J Med
|
1984
|
0.80
|
65
|
Aortitis syndrome (Takayasu's arteritis) associated with SLE.
|
J Rheumatol
|
1990
|
0.80
|
66
|
Cartilage repair and conservation in osteoarthritis. A brief review of some experimental approaches to chondroprotection.
|
Rheum Dis Clin North Am
|
1993
|
0.79
|
67
|
Hepatocyte growth factor and its actions in growth plate chondrocytes.
|
Bone
|
1996
|
0.79
|
68
|
Relapsing polychondritis: commentary.
|
Reumatismo
|
2003
|
0.78
|
69
|
Subcutaneous cholesterol crystals mimicking calcinosis cutis in systemic sclerosis.
|
J Rheumatol
|
1991
|
0.78
|
70
|
Elevated plasma histamine levels in systemic sclerosis (scleroderma).
|
Arch Dermatol
|
1990
|
0.78
|
71
|
Osteoarthritis: definitions and criteria.
|
Ann Rheum Dis
|
1990
|
0.78
|
72
|
Treatment of canine osteoarthritis with sodium pentosan polysulfate and insulin-like growth factor-1.
|
Ann N Y Acad Sci
|
1994
|
0.78
|
73
|
The selective value of computed tomography of the brain in cerebritis due to systemic lupus erythematosus.
|
J Rheumatol
|
1983
|
0.78
|
74
|
Clinical research: assessing the future in a changing environment; summary report of conference sponsored by the American Medical Association Council on Scientific Affairs, Washington, DC, March 1996.
|
Am J Med
|
1998
|
0.78
|
75
|
[Various aspects of the epidemiology of osteoarthritis].
|
Rev Rhum Ed Fr
|
1994
|
0.78
|
76
|
Chondroprotection in osteoarthritis.
|
Bull Rheum Dis
|
1997
|
0.77
|
77
|
Amelioration of lapine osteoarthritis by treatment with glycosaminoglycan-peptide association complex (Rumalon).
|
Arthritis Rheum
|
1991
|
0.77
|
78
|
New directions in therapy of osteoarthritis.
|
Semin Arthritis Rheum
|
1987
|
0.77
|
79
|
Acute myositis and dermatitis as the initial presentation of sarcoidosis.
|
Clin Exp Rheumatol
|
1994
|
0.77
|
80
|
Recent clinical experience in the management of gonococcal arthritis.
|
J Fla Med Assoc
|
1969
|
0.77
|
81
|
Chronic pain states: pathophysiology and medical therapy.
|
Semin Arthritis Rheum
|
1997
|
0.76
|
82
|
Arthroscopic findings of the knee in patients with pseudogout.
|
Arthritis Rheum
|
1976
|
0.76
|
83
|
Plasma somatomedin-C levels in systemic sclerosis.
|
Br J Dermatol
|
1988
|
0.76
|
84
|
Synthetic human calcitonin in refractory Paget's disease of bone.
|
Arch Intern Med
|
1987
|
0.76
|
85
|
The effects of a partially purified fraction of an ant venom in rheumatoid arthritis.
|
Arthritis Rheum
|
1984
|
0.75
|
86
|
Efficacy of intraarticular hyaluronan in the treatment of knee osteoarthritis: comment on the article by Brandt et al.
|
Arthritis Rheum
|
2001
|
0.75
|
87
|
Use of opioids to treat chronic, noncancer pain.
|
West J Med
|
2000
|
0.75
|
88
|
Chronic pain states: invasive procedures.
|
Semin Arthritis Rheum
|
1997
|
0.75
|
89
|
Paget's disease of bone (osteitis deformans).
|
Bull Rheum Dis
|
1984
|
0.75
|
90
|
Mandibular bone erosion and scleroderma.
|
Arthritis Rheum
|
1977
|
0.75
|
91
|
Scalp vein sign in Paget's disease of bone.
|
J Rheumatol
|
1982
|
0.75
|
92
|
Method for calculating costs of steam sterilization devised.
|
Hospitals
|
1979
|
0.75
|
93
|
Arthroscopy of the knee.
|
Semin Arthritis Rheum
|
1983
|
0.75
|
94
|
Cerebral atrophy in systemic lupus erythematosus: steroid- or disease-induced phenomenon?
|
AJNR Am J Neuroradiol
|
1982
|
0.75
|
95
|
The effect of glycosaminoglycan polysulfuric acid ester on articular cartilage in experimental arthritis: effects on collagenolytic enzyme activity and cartilage swelling properties.
|
J Rheumatol
|
1987
|
0.75
|
96
|
Risedronate in Paget's disease: preliminary results of a multicenter study.
|
Semin Arthritis Rheum
|
1994
|
0.75
|
97
|
Osteoarthritis. Aggravating factors and therapeutic measures.
|
Postgrad Med
|
1986
|
0.75
|
98
|
The course of systemic lupus erythematosus in a subtropical medical center.
|
J Fla Med Assoc
|
1969
|
0.75
|
99
|
Gout presenting as infectious arthritis. Two case reports.
|
J Bone Joint Surg Am
|
1994
|
0.75
|
100
|
Enlarged acetabular labra in the Pima Indians.
|
J Rheumatol
|
1997
|
0.75
|
101
|
Report of the American Medical Association (AMA) Council on Scientific Affairs and AMA recommendations to medical professional staff on the use of wireless radio-frequency equipment in hospitals.
|
Biomed Instrum Technol
|
2001
|
0.75
|
102
|
A comprehensive regimen for osteoarthritis.
|
Med Clin North Am
|
1971
|
0.75
|